Algatechnologies and FujiFilm to promote natural astaxanthin

Published: 9-Jun-2015

Algatechnologies has signed a supply and long-term collaboration agreement with Fujifilm Corp. (Fujifilm) in Japan for its AstaPure natural astaxanthin ingredients

Fujifilm recently took over Algatech’s major distributor in Japan and will promote astaxanthin raw materials.

The company has already been using Algatech’s natural astaxanthin as the main active ingredient for its Astalift nutrition supplement and cosmetics product line.

‘Astalift is one of the most innovative and successful cosmetics brands in Japan,’ says Yutaka Yamaguchi, Head of the Life Science Products Division for Fujifilm. ‘This is due to state-of-the-art collagen technology and nanotechnology cultivated for our photo film products, coupled with the high antioxidant astaxanthin from Algatech. The Astalift line has built an impressive reputation as an anti-aging cosmetics brand.’

‘Natural astaxanthin is a key ingredient for us,’ continues Yamaguchi: ‘It was a strategic decision to expand our business portfolio in Japan by supplying astaxanthin in bulk quantities and multiple unique delivery formats. We have chosen AstaPure astaxanthin based on its high quality parameters and the reliable — and consistent — supply capabilities of Algatech.’

Ronnie Meninger, Algatech CEO, states: ‘We are proud and excited to strengthen our relationship with Fujifilm. Japan was always a major market for us, and supplying our ingredient to Fujifilm for its Astalift line is an important distinction for us.’

‘We are certain the solid reputation of Fujifilm for quality control/assurance, and its strong credibility in the Japanese market, combined with Algatech’s expertise in astaxanthin production and development of other special active ingredients from microalgae, will increase our leading position in Japan and the rest of the world,’ Ronnie concluded.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
  2. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like